These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2894994)

  • 21. Effect of antiischemic therapy on coronary flow reserve and the pressure-maximal coronary flow relationship in anesthetized swine.
    McFalls EO; Duncker DJ; Sassen LM; Gho BC; Verdouw PD
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):827-36. PubMed ID: 1725894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
    Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
    Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
    Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
    Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-adrenoceptor blockade on exercise performance and metabolism.
    Lundborg P; Aström H; Bengtsson C; Fellenius E; von Schenck H; Svensson L; Smith U
    Clin Sci (Lond); 1981 Sep; 61(3):299-305. PubMed ID: 7261552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The actions of the beta-adrenoceptor blocking agents propranolol and metoprolol in the maximally exercised horse.
    Snow DH; Summers RJ; Guy PS
    Res Vet Sci; 1979 Jul; 27(1):22-9. PubMed ID: 574307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris.
    Riley M; Elborn JS; Khan MM; Stanford CF; Nicholls DP
    Eur Heart J; 1992 Aug; 13(8):1116-22. PubMed ID: 1354616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
    J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol).
    Erikssen J; Thaulow E; Mundal R; Opstad P; Nitter-Hauge S
    Br J Clin Pharmacol; 1982; 13(Suppl 2):201S-209S. PubMed ID: 6125171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
    Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
    Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular function during treatment with either metoprolol or epanolol.
    Evans T
    Drugs; 1989; 38 Suppl 2():70. PubMed ID: 2575986
    [No Abstract]   [Full Text] [Related]  

  • 40. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA
    Eur J Clin Pharmacol; 1994; 46(3):279-82. PubMed ID: 7915237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.